346 related articles for article (PubMed ID: 18972404)
1. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sun BS; Dong QZ; Ye QH; Sun HJ; Jia HL; Zhu XQ; Liu DY; Chen J; Xue Q; Zhou HJ; Ren N; Qin LX
Hepatology; 2008 Dec; 48(6):1834-42. PubMed ID: 18972404
[TBL] [Abstract][Full Text] [Related]
2. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sheng SL; Liu JJ; Dai YH; Sun XG; Xiong XP; Huang G
FEBS J; 2012 Oct; 279(20):3898-910. PubMed ID: 22897481
[TBL] [Abstract][Full Text] [Related]
5. Segment-specific targeting via RNA interference mediates down-regulation of OPN expression in hepatocellular carcinoma cells.
Lin F; Huang CM; Cao J; Pei ZH; Gu WL; Fan SF; Li KP; Lin CM
Genet Mol Res; 2015 Nov; 14(4):14440-7. PubMed ID: 26600502
[TBL] [Abstract][Full Text] [Related]
6. [Effects of MIM-B gene on invasive and metastatic potentials of human hepatocellular carcinoma MHCC97H cells].
Huang XY; Huang ZL; Xu YH; Huang XY; Zhou J; Ye SL; Tang ZY; Zheng Q
Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):915-9. PubMed ID: 21205477
[TBL] [Abstract][Full Text] [Related]
7. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
Liu H; Chen A; Guo F; Yuan L
Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.
Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y
Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021
[TBL] [Abstract][Full Text] [Related]
9. Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells.
Wang ZM; Cui YH; Li W; Chen SY; Liu TS
Oncol Rep; 2011 Apr; 25(4):997-1003. PubMed ID: 21286666
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.
Jia XQ; Cheng HQ; Qian X; Bian CX; Shi ZM; Zhang JP; Jiang BH; Feng ZQ
Cell Biochem Biophys; 2012 Jan; 62(1):237-44. PubMed ID: 21847633
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression.
Chen RX; Xia YH; Xue TC; Ye SL
Mol Biol Rep; 2011 Aug; 38(6):3671-7. PubMed ID: 21104439
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis.
Sun BS; You J; Li Y; Zhang ZF; Wang CL
Chin Med J (Engl); 2013; 126(9):1683-8. PubMed ID: 23652051
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285
[TBL] [Abstract][Full Text] [Related]
14. [Identification of metastasis-related osteopontin expression and glycosylation in hepatocellular carcinoma].
Sun HY; Li Y; Guo K; Kang XN; Sun C; Liu YK
Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):904-7. PubMed ID: 22525502
[TBL] [Abstract][Full Text] [Related]
15. Des-γ-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway.
Yue P; Gao ZH; Xue X; Cui SX; Zhao CR; Yuan Y; Yin Z; Inagaki Y; Kokudo N; Tang W; Qu XJ
Eur J Cancer; 2011 May; 47(7):1115-24. PubMed ID: 21349701
[TBL] [Abstract][Full Text] [Related]
16. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump.
Lu X; Qin W; Li J; Tan N; Pan D; Zhang H; Xie L; Yao G; Shu H; Yao M; Wan D; Gu J; Yang S
Cancer Res; 2005 Aug; 65(15):6843-9. PubMed ID: 16061667
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin promotes the progression of gastric cancer through the NF-κB pathway regulated by the MAPK and PI3K.
Liu J; Liu Q; Wan Y; Zhao Z; Yu H; Luo H; Tang Z
Int J Oncol; 2014 Jul; 45(1):282-90. PubMed ID: 24756245
[TBL] [Abstract][Full Text] [Related]
18. JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
J Biol Chem; 2005 May; 280(19):19381-92. PubMed ID: 15757900
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Met promotes hepatocellular carcinoma tumorigenesis and metastasis by upregulation of TAK1 and activation of NF-κB pathway.
Tey SK; Tse EYT; Mao X; Ko FCF; Wong AST; Lo RC; Ng IO; Yam JWP
Cancer Lett; 2017 Dec; 411():150-161. PubMed ID: 28989054
[TBL] [Abstract][Full Text] [Related]
20. [Effects of high metastatic potential hepatocellular carcinoma cell-binding peptide on the invasion and metastasis of liver cancer].
Jia WD; Wang W; Tang ZY; Xu GL; Sun HC; Zhou HJ
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):241-5. PubMed ID: 19615273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
